Dripco. LLC d/b/a Dripco Vape Company – FDA Warning Letter, Feb 26, 2021

The FDA's Center for Tobacco Products reviewed https://vapedripco.com and determined that e-liquid products, specifically Beggars Brew Vagabond and Beggars Brew Salt HOBO, are manufactured and offered for sale or distribution in the U.S. These products are classified as tobacco products under section 201(rr) of the FD&C Act and are subject to FDA jurisdiction.

The key violation identified is the marketing of "new tobacco products" without required premarket authorization. A "new tobacco product" is defined as any tobacco product not commercially marketed in the U.S. as of February 15, 2007, or any modified product marketed after this date. The e-liquid products in question were not commercially marketed by the specified date and lack an FDA marketing authorization order, nor are they exempt. Consequently, these products are deemed adulterated under section 902(6)(A) and misbranded under section 903(a)(6) of the FD&C Act due to the absence of required information under section 905(j).

The firm, a registered manufacturer with over 1,100 products listed with FDA, is responsible for ensuring compliance across all its tobacco products, labeling, and advertising. Failure to address these violations may result in regulatory actions including civil money penalties, seizure, and/or injunction. The FDA requires a written response within 15 working days detailing corrective